Guidelines for COVID-19 antivirals revealed but GPs warned of shortages
The first stocks will be held in the National Medical Stockpile
The first Australian guidelines for the two new COVID-19 antivirals that GPs can prescribe warn that one of them — molnupiravir — should be prescribed only as a last resort.
The Federal Government has ordered 500,000 courses of nirmatrelvir-ritonavir (Paxlovid) and 300,000 courses of molnupiravir (Legavrio), but global demand has left both drugs in short supply.
As a result it is expected that initially GPs will initially access them through the National Medical Stockpile
